Relenza Powder
Product Images NDC 50090-8016

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Relenza (NDC 50090-8016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500908016)

Packaging label for RELENZA (zanamivir) powder, 20 mg per rotadisk with 5 mg per blister. The label indicates 20 blisters per package and includes warnings to keep out of children's reach and dispense in a tight, light-resistant container. Manufactured or packaged exclusively by A-S Medication Solutions, Libertyville, IL. The label includes a barcode and instructions to use the drug as ordered by a doctor.*

FDA Label Image

Zanamivir Structural Formula (Relenza Spl Graphic 01)

Chemical structure of zanamivir, the active ingredient in RELENZA 5 mg inhalation powder. The diagram depicts the molecular arrangement and bonding of the zanamivir compound.*

FDA Label Image

Parts Of The Diskhaler (Relenza Spl Graphic 02)

An instructional diagram labeling parts of the RELENZA DISKHALER device, showing components including the cover, white mouthpiece, dark brown wheel, white tray, raised ridges, needle, DISKHALER body, half-circle flap, and a silver medicine disk containing four blisters of medicine for inhalation powder use.*

FDA Label Image

Figure A (Relenza Spl Graphic 03)

An instructional illustration showing the RELENZA dry powder inhaler device held in one hand, with the other hand removing the blue protective cap by pulling it in the direction indicated by a white arrow. The inhaler is labeled with the RELENZA brand name and dosage information.*

FDA Label Image

Figure B (Relenza Spl Graphic 04)

Illustration showing hands holding a RELENZA powder inhaler for respiratory inhalation. The image demonstrates the proper technique to use the inhaler by sliding the white mouthpiece in the direction of the arrow for activating the device.*

FDA Label Image

Figure C (Relenza Spl Graphic 05)

An instructional illustration showing how to operate the RELENZA inhalation device containing zanamivir powder 5 mg. It highlights the action of pressing the device to load a dose, focusing on ridges on the inhaler’s rotating component and hand positioning for pushing to activate the dose release mechanism.*

FDA Label Image

Figure D (Relenza Spl Graphic 06)

An instructional image showing a person's hands holding a RELENZA inhalation device with a foil blister pack containing 5 mg zanamivir powder for respiratory use. The user is removing the foil seal from the blister prior to insertion into the inhaler device.*

FDA Label Image

Figure E (Relenza Spl Graphic 07)

An instructional illustration showing hands operating a RELENZA inhalation device. The device is labeled with the RELENZA brand name and dosage strength (5 mg) for zanamivir powder. The image includes an arrow indicating the direction to slide or activate part of the inhaler for use.*

FDA Label Image

Figure F (Relenza Spl Graphic 08)

An instructional illustration showing a hand holding a DISKHALER device horizontally. A pink speech bubble advises, "Be sure to keep the DISKHALER level." This image is intended to guide proper use of the inhalation device for RELENZA powder.*

FDA Label Image

Figure G (Relenza Spl Graphic 09)

An instructional illustration showing hands holding a RELENZA inhalation device as the powder cartridge is being inserted or removed, demonstrating how to load or unload the 5 mg zanamivir powder for respiratory inhalation.*

FDA Label Image

Figure H (Relenza Spl Graphic 10)

An instructional illustration showing hands holding and rotating a device used for inhalation. The device is likely the respiratory inhalation powder applicator for RELENZA (zanamivir) 5 mg. A curved arrow indicates the direction of rotation of the device's top portion.*

FDA Label Image

Figure I (Relenza Spl Graphic 11)

Illustration showing a woman using a device to inhale RELENZA powdered medication for respiratory delivery, demonstrating the inhalation technique with the inhaler held near her mouth.*

FDA Label Image

Figure J (Relenza Spl Graphic 12)

An instructional illustration showing a woman using the RELENZA inhalation device. The image focuses on the proper technique where the user places the device to her mouth to inhale the powder medication.*

FDA Label Image

Figure K (Relenza Spl Graphic 13)

Instructional illustration showing hands operating a RELENZA inhalation device to prepare the 5 mg/1 powder dose for respiratory delivery. The image demonstrates how to load or open the device for use.*

FDA Label Image

Figure L (Relenza Spl Graphic 14)

An instructional diagram showing hands holding a RELENZA (zanamivir) inhalation device, demonstrating how to click or activate the device by pressing with the thumb and forefinger along the indicated direction.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.